LY404187

CAS No. 211311-95-4

LY404187( —— )

Catalog No. M21047 CAS No. 211311-95-4

LY404187 is a positive allosteric modulator of AMPA receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 72 Get Quote
10MG 125 Get Quote
25MG 250 Get Quote
50MG 376 Get Quote
100MG 536 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LY404187
  • Note
    Research use only, not for human use.
  • Brief Description
    LY404187 is a positive allosteric modulator of AMPA receptors.
  • Description
    LY404187 is a positive allosteric modulator of AMPA receptors.
  • In Vitro
    LY-404187 (3-10 nM) potentiates glutamate-evoked inward currents in human GluR4 transfected HEK293 cells.LY-404187 (0.03-10 μM) selectively enhances glutamate-evoked currents through AMPA receptor/channels of acutely isolated pyramidal neurons with considerably greater potency (EC50=1.3±0.3 μM) and efficacy (Emax=45.3±8.0-fold increase) .LY-404187 does not affect the magnitude or time course of wholecell K+ or Na+ currents in pre frontal cortex (PFC) pyramidal neurons at concentrations of 10 μM.
  • In Vivo
    LY-404187 (0.5 mg/kg; s.c for 11 days) can prevent MPTP-induced neurotoxicity in mice.LY-404187 (0.5 mg/kg; s.c. for 28 days) attenuates apomorphine-induced contraversive rotations and affords significant protection against the loss of tyrosine hydroxylase positive nigral cell bodies.LY-404187 (0.1 or 0.5 mg/kg; s.c. for 14 days) affords functional, neurochemical and histological protection after infusion of 6-hydroxydopamine into the substantia nigra in rats.LY-404187 (0.5 mg/kg; s.c. for 14 days) delayed treatment provides functional and histological improvement, suggesting a trophic action as administration is initiated after cell death.LY-404187 (0.1 and 0.5 mg/kg; s.c. for 14 days) increases GAP-43 immunoreactivity in the striatum in a dose-dependent manner. Animal Model:Male C57BL/6J mice (20-25 g) are challenged with MPTP on day 8 Dosage:0.5 mg/kg Administration:S.c; twice daily on weekdays and once daily at weekends for 11 days Result:Attenuated the loss of tyrosine hydroxylase immunoreactivity in the substantia nigra.No significant change in tyrosine hydroxylase immunoreactivity in the dorsal and ventral striatum.
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    AMPA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    211311-95-4
  • Formula Weight
    342.46
  • Molecular Formula
    C19H22N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (292.00 mM)
  • SMILES
    CC(CNS(=O)(=O)C(C)C)c1ccc(-c2ccc(C#N)cc2)cc1
  • Chemical Name
    2-Propanesulfonamide N-(2-(4'-cyano(11'-biphenyl)-4-yl)propyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Quirk J C Nisenbaum E S . LY404187: A novel positive allosteric modulator of AMPA receptors[J]. Cns Drug Reviews 2002 8(3):255-282.
molnova catalog
related products
  • GLPG0634 analogue

    GLPG0634 (analog) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively.

  • ML289

    ML289 (VU0463597) is a potent, selective, and CNS-penetrant negative allosteric modulator of mGlu3 (IC50=0.66 μM), with over 15-fold selectivity compared to mGlu2 and no activity against mGlu5.

  • LY2608204

    LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.